{
    "title": "Novartis picks Centerview to explore sale of dermatology unit -sources",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-5044379/Novartis-picks-Centerview-explore-sale-dermatology-unit-sources.html",
    "date": "2017-11-02",
    "keywords": [
        "dermatology",
        "novartis",
        "sandoz",
        "business",
        "sale",
        "pamela",
        "centerview",
        "portfolio",
        "deal",
        "schuetze",
        "londonfrankfurt",
        "drugmaker",
        "matter",
        "mandate",
        "purchase",
        "firm",
        "accelerator",
        "aaa",
        "way",
        "anything",
        "atopic",
        "dermatitis",
        "price",
        "pressure",
        "plant",
        "colorado",
        "interest",
        "equity",
        "industry",
        "cautioning",
        "process",
        "stage",
        "basel",
        "kern",
        "edouard",
        "substance",
        "antipyrine",
        "agent",
        "cibageigy",
        "healthcare",
        "market",
        "value",
        "bolton",
        "product",
        "range",
        "none",
        "sector",
        "year",
        "care",
        "specialist",
        "amlactin",
        "control",
        "fougera",
        "acquisition",
        "eyecare",
        "unit",
        "billion35",
        "decision",
        "growth",
        "joe",
        "jimenez",
        "trigger",
        "reporting",
        "fenton"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}